Over the course of the forecast period, market expansion is anticipated to be driven by rising research and development initiatives by key players in the market for expanding the worldwide pneumococcal vaccines market. For instance, in June 2020, UNICEF and Serum Institute of India (SII), an Indian biopharmaceutical company, signed a new supply agreement to provide pneumococcal conjugate vaccine (PCV) in low-income nations like Pakistan, Nigeria, Uganda, and Kenya for US$ 2.00 per dose, a 43% discount from the Gavi price at the beginning of the Advance Market Commitment.
Global Pneumococcal Vaccines Market size was valued at US$ 6,615.94 Million in 2022 and is expected to witness a CAGR of 4.4% over the forecast period (2022 – 2030).
Top Companies in the Pneumococcal Vaccines Industry:
1. Pfizer Inc.
Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sell biopharmaceutical products worldwide. In December, 2022 announced the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third 3-µg dose in the three-dose primary series for children 6 months through 4 years of age.
2. Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
3. GlaxoSmithKline plc
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GSK plc and Wave Life Sciences Ltd in December, 2022 announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s preclinical RNA editing programme targeting alpha-1 antitrypsin deficiency (AATD), WVE-006.
*Definition - To avoid infection brought on by the bacteria Streptococcus pneumoniae, pneumococcal vaccination is administered. The pneumococcal conjugate vaccine and the pneumococcal polysaccharide vaccine are the two different forms of pneumococcal vaccinations.
